Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study
Author:
Funder
Northern Norway Regional Health Authority
Helse Sør-Øst RHF
Publisher
Elsevier BV
Subject
Health Policy,Medicine (miscellaneous)
Reference53 articles.
1. Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: A drug utilization study from 2014 to 2017;Aas;Substance Abuse Treatment, Prevention, and Policy,2020
2. Assessing hepatitis C spontaneous clearance and understanding associated factors—A systematic review and meta-analysis;Aisyah;Journal of Viral Hepatitis,2018
3. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents;Alavi;Liver International,2014
4. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study;Bajis;Journal of Viral Hepatitis,2020
5. The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; real-world data 2011–2018;Bardsley;Journal of viral hepatitis,2021
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study;International Journal of Drug Policy;2024-07
2. Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial;Viruses;2024-05-27
3. Monitoring Progress Towards the Elimination of Hepatitis C as a Public Health Threat in Norway: A Modelling Study Among People Who Inject Drugs and Immigrants;The Journal of Infectious Diseases;2024-03-27
4. Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs;International Journal of Drug Policy;2024-01
5. Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis;The Lancet Regional Health - Europe;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3